When it comes to medications, Americans are skeptical.
Many assume their doctors — and expert bloggers on health sites — prescribe or promote certain drugs because pharmaceutical companies pay them to do so. A 2013 Harris Poll showed only 28 percent of Americans think their hospital is trustworthy.
A little healthy skepticism is fair. Doctors are not all immune to influence. In the past two decades, there has been an increase in industry spending to get doctors to promote certain drugs or medical devices.
However, don’t just assume your doctor takes money for consulting or promotion. Many — including myself — require that any money offered for consulting on drug trials goes to charity. And public policy is changing to give you more transparency about the industry.
When you assess how trustworthy your own doctor or hospital are, keep the following in mind.
More transparency is coming
Congress took a big step in promoting transparency with the Physician Payments Sunshine Act, which went into effect Aug. 1, 2013.
Patients need transparency to know doctors are providing the care that is best for them. Patients also need treatments that improve their health. With the right safeguards in place, patients can have both.
Companies that make drugs and medical devices now must report any payments or items they provide to physicians or teaching hospitals worth $10 or more.
That information will be available to you. On September 30, 2014, the Centers for Medicare and Medicaid Services will release an online database containing the reports for public viewing.
Disclosure is not a cure-all — but it’s a step in the right direction.
Many hospitals require disclosure
Many hospitals have taken their own steps to make disclosure public.
For example, Cleveland Clinic requires doctors to disclose any industry relationships or funding. You can find such disclosure on every doctor’s page in the staff directory listing.
Other hospital systems have similar policies in place. On top of that, there are “watchdog” groups that track such information.
Put the industry in perspective
When it’s appropriate, I am critical of the industry. But I also believe we need a vibrant pharmaceutical industry. It’s where many life-saving developments — from better treatments for heart failure to longer-lasting blood thinners — come from.
That is why doctors devote so much time to studies on the effectiveness and safety of drugs. For example, we are performing a large-scale study to determine which nonsteroidal anti-inflammatory drugs (NSAIDs) are safest for your heart.
It all comes down to patient needs. Patients need transparency to know doctors are providing the care that is best for them. Patients also need treatments that improve their health. With the right safeguards in place, patients can have both.